SCHEMBL7989385

SCHEMBL7989385

NC(=O)c1c(NC(=O)c2ccccc2)ncn1Cc1ccc(Cl)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.47
TSHR P16473 2/20 0.42
KDM4E B2RXH2 3/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
EPHX2 P34913 2/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
NPSR1 Q6W5P4 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
PMP22 Q01453 1/20 0.40
HIF1A Q16665 1/20 0.40
ACP1 P24666 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PTGER1 P34995 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985416 0.89 LMNA (0.50) KDM4ELMNAALDH1A1HPGDNPSR1
SCHEMBL7974581 0.86 LMNA (0.51) PPARGTSHRLMNAALDH1A1HPGD
SCHEMBL7974040 0.84 KDM4E (0.51) TSHRKDM4EALDH1A1NPC1RAB9A
SCHEMBL7988029 0.84 IDO1 (0.47) TSHRLMNARXFP1NPC1RAB9A
SCHEMBL7975241 0.83 GAA (0.50) TSHRLMNARXFP1NPC1RAB9A
SCHEMBL7984492 0.83 ADORA2A (0.53) KDM4EALDH1A1
SCHEMBL7985708 0.82 NPC1 (0.49) TSHRKDM4EALDH1A1HPGDNPSR1
SCHEMBL7991817 0.81 KDM4E (0.51) KDM4ELMNAALDH1A1HPGDCYP1A2
SCHEMBL7984751 0.81 NTRK1 (0.46) PPARGKDM4ELMNAALDH1A1HPGD
SCHEMBL7973841 0.78 RAB9A (0.47) TSHRLMNAALDH1A1RXFP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed